Skip to main content

Animations

MJFF Publications

8221 - 8230 of 8666 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2023
  • 2018
  • 2016
  • 2019
  • 2016
  • 2021
  • 2017
  • 2015
  • Summary Details
    OPEN
    Title: Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2018.03.012
    Citation Count: 179
  • Summary Details
    OPEN
    Title: Contrast Acuity With Different Colors in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12821
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Toward a standard model for autophagosome biogenesis
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa, cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.202304011
    Citation Count: 19
  • Summary Details
    RESTRICTED
    Title: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018
    Best OA location URL:
    Citation Count: 33
  • Summary Details
    RESTRICTED
    Title: Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26882
    Best OA location URL:
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104525
    Citation Count: 82
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 199
  • Summary Details
    OPEN
    Title: T lymphocyte senescence is attenuated in Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-021-02287-9
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamine
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Compensatory neural mechanisms in cognitively unimpaired Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nd
    DOI - Digital Object Identifier: 10.1002/ana.24585
    Citation Count: 70
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.